Semnur Pharmaceuticals SMNR
OTC SMNR
$0.37 -0.01 (-2.63%)
At close: Oct 23, 2026 · 4:00 PM EDT

Semnur Pharmaceuticals (SMNR) Non Operating Income (2026)

Updated

Semnur Pharmaceuticals (SMNR) reported Non Operating Income of -$123,000 for Q2 2026.

Analysis

Semnur Pharmaceuticals (SMNR) Non Operating Income (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 269.00 Mn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn -
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn -
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn -
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -73.00 Mn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 387.00 Mn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn -
10 Semnur Pharmaceuticals 85.18 Mn 84.92 Mn - -123,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -123,000.00
API Access

Semnur Pharmaceuticals Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=SMNR&period=max&api_key=YOUR_API_KEY